New HIV combo shows promise against deadly brain virus
NCT ID NCT00120367
First seen Apr 03, 2026 · Last updated May 13, 2026 · Updated 4 times
Summary
This study tested whether adding a powerful HIV drug called FUZEON® to standard antiretroviral therapy could help people with HIV who have a rare brain infection called PML. PML is caused by the JC virus and usually affects people with weak immune systems. The study included 30 adults in France and followed them for one year to see if the stronger drug combination could stop the brain infection from getting worse and improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service de Medecine interne et Maladies Infectieuses, Hopital Bicetre
Le Kremlin-Bicêtre, 94270, France
Conditions
Explore the condition pages connected to this study.